Andreas Wicki - Dissemin

Language
Login

All papers authored by Andreas Wicki

This paper was not found in any repository, but could be made available legally by the author.

2022 Jan Ben Schulze, Moritz Philipp Günther, Cosima Riemenschnitter, Andreas Wicki

ORCID

, Roland von Känel, Sebastian Euler

Distinct psycho-oncological support inclinations and needs in patients with cancer: A large sample latent class analysis approach

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

B. Kasenda, D. König, M. Manni, R. Ritschard, U. Duthaler, E. Bartoszek, A. Bärenwaldt, S. Deuster, G. Hutter, D. Cordier, L. Mariani, J. Hench, S. Frank, S. Krähenbühl, A. Zippelius

ORCID

and 4 other authors

Targeting immunoliposomes to EGFR-positive glioblastoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

Cyrill A. Rentsch, George N. Thalmann, Ilaria Lucca, Maciej Kwiatkowski, Grégory J. Wirth, Räto T. Strebel, Daniel Engeler, Augusto Pedrazzini, Clemens Hüttenbrink, Wolfgang Schultze-Seemann, Raimund Torpai, Lukas Bubendorf, Andreas Wicki

ORCID

, Beat Roth, Heike Püschel and 8 other authors

A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

Upload

This paper was not found in any repository, but could be made available legally by the author.

2021 Anja Irmisch, Ximena Bonilla, Stéphane Chevrier, Kjong-Van Lehmann, Franziska Singer, Nora C. Toussaint, Cinzia Esposito, Julien Mena, Emanuela S. Milani, Ruben Casanova, Daniel J. Stekhoven, Rebekka Wegmann, Francis Jacob, Bettina Sobottka, Sandra Goetze

ORCID

and 105 other authors

The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support

Upload

This paper is made freely available by the publisher.

2020 Stefan G. Stark, Bernd Wollscheid, Shuqing Yu, Johanna Ziegler, Marc Zimmermann, Martin Zoche, Gregor Zuend, Joanna Ficek, Francesco Locatello, Ximena Bonilla, Stéphane Chevrier, Franziska Singer, Rudolf Aebersold, Faisal S. Al-Quaddoomi, Jonas Albinus and 105 other authors

SCIM: universal single-cell matching with unpaired feature sets.

Download from academic.oup.com

This paper was not found in any repository, but could be made available legally by the author.

Thibaud Koessler, Viola Paradiso, Salvatore Piscuoglio

ORCID

, Ronny Nienhold, Liza Ho, Yann Christinat, Luigi M. Terracciano, Gieri Cathomas, Andreas Wicki

ORCID

, Thomas A. McKee, Thierry Nouspikel

Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platforms

Upload

Distributing this paper is prohibited by the publisher

Cyrill A. Rentsch, Grégoire Mayor, Malte Rieken, Heike Püschel, Grégory Wirth, Richard Cathomas, Gerald P. Parzmair, Leander Grode, Bernd Eisele, Hitt Sharma, Manish Gupta, Sunil Gairola

ORCID

, Umesh Shaligram, Daniel Goldenberger, François Spertini and 6 other authors

Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy

Upload

This paper was not found in any repository, but could be made available legally by the author.

2019 Dirk L. Kienle, Daniel Dietrich, Karin Ribi

ORCID

, Andreas Wicki

ORCID

, Luca Quagliata, Ralph C. Winterhalder, Dieter Koeberle, Daniel Horber, Sara Bastian, Marc Kueng, Piercarlo Saletti, Daniel Helbling

ORCID

, Daniela Baertschi, Alessandro Lugli, Juerg Bernhard and 2 other authors

Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 Michèle Voegeli, Andreas Wicki

ORCID

Neoadjuvante, adjuvante und palliative onkologische Therapie beim kolorektalen Karzinom

Upload

This paper is made freely available by the publisher.

Raphael Sexauer, Thomas Weikert

ORCID

, Kevin Mader, Andreas Wicki

ORCID

, Sabine Schädelin, Bram Stieltjes, Jens Bremerich

ORCID

, Gregor Sommer

ORCID

, Alexander W. Sauter

ORCID

Towards More Structure: Comparing TNM Staging Completeness and Processing Time of Text-Based Reports versus Fully Segmented and Annotated PET/CT Data of Non-Small-Cell Lung Cancer

Download from doi.org

This paper is made freely available by the publisher.

Franziska Singer, Anja Irmisch, Nora C. Toussaint, Linda Grob, Jochen Singer, Thomas Thurnherr, Niko Beerenwinkel, Mitchell P. Levesque, Reinhard Dummer, Luca Quagliata, Sacha I. Rothschild, Andreas Wicki

ORCID

, Christian Beisel, Daniel J. Stekhoven

ORCID

SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Andreas Wicki

ORCID

, Nicholas Brown, Alexandros Xyrafas, Vincent Bize, Hanne Hawle, Simona Berardi, Nataša Cmiljanović, Vladimir Cmiljanović, Michael Stumm, Saša Dimitrijević, Richard Herrmann, Vincent Prêtre, Reto Ritschard, Alexandar Tzankov, Viviane Hess and 8 other authors

First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)

Upload

This paper was not found in any repository, but could be made available legally by the author.

Akiko Kunita, Vanessa Baeriswyl, Claudia Meda, Erik Cabuy

ORCID

, Kimiko Takeshita, Enrico Giraudo, Andreas Wicki

ORCID

, Masashi Fukayama, Gerhard Christofori

Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front

Upload

This paper was not found in any repository, but could be made available legally by the author.

Vincent Prêtre, Andreas Wicki

ORCID

Inhibition of Akt and other AGC kinases: A target for clinical cancer therapy?

Upload

This paper is made freely available by the publisher.

2017 Chiara Tarantelli, Eugenio Gaudio, Alberto J. Arribas, Ivo Kwee, Petra Hillmann, Andrea Rinaldi, Luciano Cascione, Filippo Spriano, Elena Bernasconi, Francesca Guidetti, Laura Carrassa, Roberta Bordone Pittau, Florent Beaufils, Reto Ritschard, Denise Rageot and 16 other authors

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy

Download from aacrjournals.org

This paper is made freely available by the publisher.

Gongda Xue, Reto Kohler, Fengyuan Tang, Debby Hynx, Yuhua Wang, Francesca Orso

ORCID

, Vincent Prêtre, Reto Ritschard, Petra Hirschmann, Peter Cron, Tim Roloff, Reinhard Dummer, Mario Mandalà, Sandrine Bichet, Christel Genoud and 13 other authors

mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition

Download from doi.org

This paper is made freely available by the publisher.

Aino Paasinen-Sohns, Viktor H. Koelzer, Angela Frank, Julian Schafroth, Aline Gisler, Melanie Sachs, Anne Graber, Sacha I. Rothschild, Andreas Wicki

ORCID

, Gieri Cathomas, Kirsten D. Mertz

ORCID

Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Thierry M. Nordmann, Freimut D. Juengling, Mike Recher, Christoph T. Berger, Daniel Kalbermatten, Andreas Wicki

ORCID

, Aino Paasinen-Sohns, Gieri Cathomas, Alexandar Tzankov, Thomas Daikeler

Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations

Upload

This paper is made freely available by the publisher.

2016 Christoph Rochlitz, Roger von Moos, Martin Bigler, Andreas Wicki

ORCID

, Jürg Bernhard, Khalil Zaman, Kyung-Jae Na, Na Kj, Klazien Matter-Walstra

ORCID

, Sandro Anchisi, Tamara Rordorf, Marc Küng, Daniel Rauch, Daniela Bärtschi, Andreas Müller and 8 other authors

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial

Download from link.springer.com

This paper is made freely available by the publisher.

Viktor H. Koelzer, Tobias Buser, Niels Willi, Sacha I. Rothschild, Andreas Wicki

ORCID

, Peter Schiller, Gieri Cathomas, Alfred Zippelius

ORCID

, Kirsten D. Mertz

ORCID

Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy

Download from doi.org

Missing publications? Search for publications with a matching author name.